A Stanford grad and California native moved his medical device company to Ann Arbor to utilize the talent of former Pfizer staffers and U-M's technology.
Excerpt:
"Everist Genomics has developed a device called the AngioDefender that in a deceptively simple way tests the resiliency and therefore the health of a subject's blood vessels. Now marketed in India and soon to be sold in Europe and other parts of the world, the AngioDefender might one day be as synonymous with Michigan as Vernor's and Domino's."
More
here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.